Treatment of Low-Blast Count AML using Hypomethylating Agents

In 2002, the WHO classification reduced the proportion of blasts in the bone marrow (BM) necessary for the diagnosis of acute myeloid leukemia (AML) from 30% to 20%, eliminating the RAEB-t subtype of myelodysplastic syndromes (MDS). However, this AML subtype, defined as low-blast count AML (LBC-AML,...

全面介紹

Na minha lista:
書目詳細資料
發表在:Mediterr J Hematol Infect Dis
Main Authors: De Bellis, Eleonora, Fianchi, Luana, Buccisano, Francesco, Criscuolo, Marianna, Maurillo, Luca, Cicconi, Laura, Brescini, Mattia, Del Principe, Maria Ilaria, Di Veroli, Ambra, Venditti, Adriano, Amadori, Sergio, Arcese, William, Lo-Coco, Francesco, Voso, Maria Teresa
格式: Artigo
語言:Inglês
出版: Università Cattolica del Sacro Cuore 2017
主題:
Review Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5499495/
https://ncbi.nlm.nih.gov/pubmed/28698788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2017.045
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍